BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 14098214)

  • 1. [WATER RETENTION IN CIRRHOTICS. PHYSIOPATHOLOGICAL DATA AND THERAPEUTIC RESULTS].
    CONTE M; FOUET P; JACOBS C
    Bull Mem Soc Med Hop Paris; 1963 Nov; 114():1307-12. PubMed ID: 14098214
    [No Abstract]   [Full Text] [Related]  

  • 2. CIRRHOSIS--FLUID RETENTION AND ASCITES.
    VOLWILER W
    Mod Treat; 1964 Mar; 1():451-61. PubMed ID: 14159599
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON THE DIURETIC EFFECT OF THE ADRENOSTATIC DRUG METHOPYRAPONE].
    HIERHOLZER K
    Dtsch Med Wochenschr; 1964 Jun; 89():1124-7. PubMed ID: 14152369
    [No Abstract]   [Full Text] [Related]  

  • 4. [USE OF AN INHIBITOR OF ALDOSTERONE SYNTHESIS (SU-4885, METOPIRONE) IN SOME REFRACTORY EDEMATOUS STATES].
    CURCIO R; CASSIA B
    Boll Soc Ital Cardiol; 1963; 8():563-74. PubMed ID: 14122383
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of the hydrosaline retention in hepatic cirrhosis with spironolactone].
    VELASCO M; GAZMURI R; KATZ R
    Rev Med Chil; 1961 Oct; 89():846-51. PubMed ID: 13925219
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the therapy of edemas caused by liver disease. Changes of water-salt metabolism and of the urinary corticosteroid picture in cirrhotics treated with prednisone, spirolactone and methopyrone].
    PUPITA F; DE MARTINIS C
    Minerva Med; 1961 Dec; 52():4557-62. PubMed ID: 14489229
    [No Abstract]   [Full Text] [Related]  

  • 7. [LIMITS OF TREATMENT OF CIRRHOSIS WITH DIURETICS (SALDIURETICS AND ALDOSTERONE ANTAGONISTS)].
    ALBEAUX-FERNET M; ROMANI JD
    Bull Mem Soc Med Hop Paris; 1963 Nov; 114():1277-84. PubMed ID: 14098211
    [No Abstract]   [Full Text] [Related]  

  • 8. [ON THE DIURETIC EFFECT OF THE ADRENOSTATIC DRUG METHOPYRAPONE].
    HIERHOLZER K
    Dtsch Med Wochenschr; 1964 Jun; 89():1167-73. PubMed ID: 14152375
    [No Abstract]   [Full Text] [Related]  

  • 9. [THE ROLE OF EDEMA IN THE REDUCTION OF DIGESTIVE ABSORPTION OF ASCORBIC ACID IN CIRRHOTICS].
    WARTER J; SCHIRARDIN H; METAIS P
    C R Seances Soc Biol Fil; 1963; 157():2085-8. PubMed ID: 14115668
    [No Abstract]   [Full Text] [Related]  

  • 10. [EFFECT OF AN ALDOSTERONE ANTAGONIST IN THERAPY RESISTANT EDEMAS].
    BARTOS V; KVASNICKA J; GROH J; ERBEN J
    Z Gesamte Inn Med; 1964 Jul; 19():588-91. PubMed ID: 14232020
    [No Abstract]   [Full Text] [Related]  

  • 11. [Spirolactone treatment of liver cirrhosis with edema and ascites].
    OFSTAD J; SIGSTAD H
    Nord Med; 1962 Jan; 67():21-4. PubMed ID: 14481210
    [No Abstract]   [Full Text] [Related]  

  • 12. [HOW TO TREAT CIRRHOTIC ASCITES IN 1963].
    RUYTERS L
    Rev Med Liege; 1963 Dec; 18():783-7. PubMed ID: 14105757
    [No Abstract]   [Full Text] [Related]  

  • 13. EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE.
    CARRUTHERS BM; LEDRAY RD; SERAGLIA M; MCINTOSH HW; WALSH GC
    Can Med Assoc J; 1963 Sep; 89(13):633-41. PubMed ID: 14077808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aldostegone-antagonistic steroids as diuretics. Spironolactone in the treatment of hepatic and cardiac edemas].
    LEPPLA W; TIEFENSEE H
    Dtsch Med Wochenschr; 1961 Dec; 86():2395-402. PubMed ID: 14464199
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of the ascites and edema of cirrhotics by spironolactone].
    MINICONI P; BOURREILLE J; SUDUCA P; CARAYON P; LAVOCAT G; ISSAD H
    Alger Medicale; 1962 Jan; 66():1-98. PubMed ID: 14474319
    [No Abstract]   [Full Text] [Related]  

  • 16. [ON THE SUBJECT OF DIURESIS WITH METOPIRONE (SU-4885)].
    CEREDA UG; FRANZINI P
    Minerva Med; 1964 Jul; 55():2335-8. PubMed ID: 14181820
    [No Abstract]   [Full Text] [Related]  

  • 17. [SECONDARY HYPERALDOSTERONISM. PHYSIOPATHOLOGIC, CLINICAL AND THERAPEUTIC CONSIDERATIONS].
    DEMARTINIS C; FONZO D
    Clin Ter; 1963 Oct; 27():51-72. PubMed ID: 14097444
    [No Abstract]   [Full Text] [Related]  

  • 18. Spironolactone (Aldactone) therapy for ascites due to cirrhosis of the liver.
    LOCKWOOD CH
    Can Med Assoc J; 1961 Sep; 85(11):631-7. PubMed ID: 13763007
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver cirrhosis and ascites.
    Bernardi M; Servadei D; Trevisani F; Rusticali AG; Gasbarrini G
    Digestion; 1985; 31(4):189-93. PubMed ID: 4007290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [THE TREATMENT OF EDEMA WITH SULFONAMIDE DIURETICS].
    BAGROS P
    Vie Med; 1964 Jan; 45():109-24. PubMed ID: 14128589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.